
KZR P/E Ratio
P/E Ratio as of Oct 29, 2025: -0.63
Average-0.5061
Median-0.4400
Minimum-0.6600
Maximum-0.3700
-0.63
Past Month-0.25 (65.79%)
The P/E ratio for KZR is -0.63 as of Oct 29, 2025. This represents a increase of 43.18% compared to its 12-month average P/E ratio of -0.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Kezar Life Sciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Kezar Life Sciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Kezar Life Sciences Inc to industry peers.
Kezar Life Sciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Kezar Life Sciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Kezar Life Sciences Inc to industry peers.
KZR P/E Ratio Insights
See Kezar Life Sciences Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in KZR
Order type
Buy in
Order amount
Est. shares
0 shares
KZR P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $3.955 | -0.41 |
| Sep 2, 2025 | $3.83 | -0.40 |
| Aug 1, 2025 | $4.05 | -0.38 |
| Jul 1, 2025 | $4.40 | -0.41 |
| Jun 2, 2025 | $4.37 | -0.41 |
| May 1, 2025 | $4.40 | -0.38 |
| Apr 1, 2025 | $4.51 | -0.39 |
| Mar 3, 2025 | $5.70 | -0.43 |
| Feb 3, 2025 | $6.22 | -0.47 |
| Jan 2, 2025 | $6.57 | -0.50 |
KZR End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.63 | +23.53% |
| 2024 | -0.51 | -34.62% |
| 2023 | -0.78 | -88.73% |
| 2022 | -6.92 | -57.13% |
| 2021 | -16.14 | +200.00% |
| 2020 | -5.38 | — |
FAQs About Kezar Life Sciences Inc (KZR) P/E ratio
The latest P/E ratio of KZR is -0.63, as of Oct 29, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Kezar Life Sciences Inc’s last 12-month average P/E ratio is -0.44, compared to its current P/E ratio of -0.63. This reflects a increase of 43.18%.
Kezar Life Sciences Inc’s current P/E ratio of -0.63 is higher than its last 12-month average P/E of -0.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Kezar Life Sciences Inc’s average P/E ratio over the last 3 years is -1.68. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Kezar Life Sciences Inc’s average P/E ratio over the last 5 years is -4.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.